Skip to main content
Clinical Trials/NCT02638311
NCT02638311
Completed
Not Applicable

Using Normal Volunteer Whole Blood or Plasma Samples to Establish the 99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test

Trinity Biotech3 sites in 1 country769 target enrollmentMay 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Coronary Syndrome
Sponsor
Trinity Biotech
Enrollment
769
Locations
3
Primary Endpoint
99th percentile for Troponin results determined from whole blood and plasma in apparetly healthy volunteer population
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Prospective multicenter sample collection and testing study.

Detailed Description

Prospective multicenter sample collection and testing study. Approximately 750 apparently healthy subjects, including healthy subjects with stable co-morbidities, age, gender and ethnicity dispersed will be eligible for enrollment

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
July 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female at least 21 years of age at the time of enrollment in the study.
  • Subjects with no medications or no changes in their medications in the last 3 months.
  • Subjects with and without chronic stable morbidities (i.e., renal insufficiency, hypertension, diabetes, hypercholesterolemia, pulmonary disorders, coronary disease, musculoskeletal disorders, etc.).
  • Subjects able to understand and sign the informed consent and the patient questionnaire.

Exclusion Criteria

  • Subjects with a history of heart failure and/or, having received treatment for heart failure.
  • Subject with renal failure.
  • Subjects with a history of unstable heart disease or angina complaints.
  • Subjects with any change in their medication in the last 3 months (diabetics may have small variations in glucose medications but may not have unstable disease, or have suffered a diabetic crisis in the last 6 months).
  • Any known acute infection in the last 30 days.
  • Marathon runners or extreme athletes.
  • Pregnant (self-reported).

Outcomes

Primary Outcomes

99th percentile for Troponin results determined from whole blood and plasma in apparetly healthy volunteer population

Time Frame: 1 day

Study Sites (3)

Loading locations...

Similar Trials